PAQR7

Chr 1

progestin and adipoQ receptor family member 7

Also known as: MPRA, PGLP, mSR

PAQR7 encodes a plasma membrane progesterone receptor that couples to G proteins and binds various neurosteroids including progesterone, DHEA, and allopregnanolone, functioning in neurosteroid signaling and inhibition of apoptosis. Mutations cause autosomal recessive microcephaly, intellectual disability, and seizures with early childhood onset. The gene is not highly constrained against loss-of-function variants, consistent with recessive inheritance requiring biallelic mutations to cause disease.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.18
Clinical SummaryPAQR7
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 53 VUS of 63 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.18LOEUF
pLI 0.000
Z-score 1.16
OE 0.63 (0.351.18)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.95Z-score
OE missense 0.82 (0.720.93)
175 obs / 214.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.63 (0.351.18)
00.351.4
Missense OE0.82 (0.720.93)
00.61.4
Synonymous OE0.92
01.21.6
LoF obs/exp: 7 / 11.2Missense obs/exp: 175 / 214.2Syn Z: 0.66
DN
0.6745th %ile
GOF
0.6833th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

63 submitted variants in ClinVar

Classification Summary

Pathogenic5
VUS53
5
Pathogenic
53
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
5
0
5
Likely Pathogenic
0
0
0
0
0
VUS
0
47
6
0
53
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total04711058

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PAQR7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →